Greetings from MyCancerHaven!
We wanted to update you on our recent activities.
We've added below videos to our Videos repository.
The video is titled
Multiple Myeloma: Introduction by Shaji Kumar MD from Professor of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, and it's been added/updated in Multiple Myeloma Category
Multiple Myeloma: Introduction by Shaji Kumar MD from Professor of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, and it's been added/updated in Multiple Myeloma Category
Ready for the return of Belantamab Mafodotin? by Ajai Chari, MD from Professor of Medicine Director of Myeloma Program University of California San Francisco , and it's been added/updated in Multiple Myeloma Category
High Risk Myeloma by Melissa Alsina MD from Professor of Medicine, Head Myeloma Section, Blood and Marrow Transplant and Cellular Immunotherapy Program, Moffitt Cancer Center, Tampa FL, and it's been added/updated in Multiple Myeloma Category
How I Manage Patients Long-Term Post CAR-T and Bispecifics Treatment by Binod Dhakal MD from Associate Professor of Medicine Division of Hematology Medical College of Wisconsin , and it's been added/updated in Multiple Myeloma Category
Multiple Myeloma: How I Treat First Relapse(1) by Brea Lipe from Professor of Medicine, Clinical Director Multiple Myeloma Program, James P. Wilmot Cancer Center, University of Rochester Medical Center, NY, and it's been added/updated in Multiple Myeloma Category
Multiple Myeloma: How I Treat First Relapse(2) by Brea Lipe from Professor of Medicine, Clinical Director Multiple Myeloma Program, James P. Wilmot Cancer Center, University of Rochester Medical Center, NY, and it's been added/updated in Multiple Myeloma Category
How to Interpret Your Test Results by Craig Emmitt Cole, MD from Division of Hematology and Oncology, Karmanos Cancer Institute at McLaren Greater Lansing, Michigan State University College of Human Medicine, and it's been added/updated in Multiple Myeloma Category
How I Use Selinexor in My Practice by Cristina Gasparetto, MD from Professor of Medicine Director of Duke Multiple Myeloma Program Duke University Medical center Durham, NC , and it's been added/updated in Multiple Myeloma Category
Peripheral Neuropathy by Beth Faiman PhD, MSN, APN-BC, BMTCN, AOCN, FAAN, FAPO from Department of Hematologic Oncology, Cleveland Clinic, Cleveland, Ohio, and it's been added/updated in Multiple Myeloma Category
How I Treat Amyloidosis by Jeffrey A. Zonder, M.D. from Professor of Medicine, Department of Oncology Barbara Ann Karmanos Cancer Institute Wayne State University School of Medicine Detroit, MI , and it's been added/updated in Multiple Myeloma Category
How I Manage The Side-Effects of Talquetamab by Dr. Joshua Richter MD from Associate Professor of Medicine Tisch Cancer Institute Director of MyelomaBlavatnik Family-Chelsea Medical Center Mount Sinai School of Medicine New York, NY , and it's been added/updated in Multiple Myeloma Category
Amyloidosis by Keith Stockerl-Goldstein MD from Co-Director of Amyloid Center of Excellence, Professor of Medicine, Division of Medical Oncology, Washington University, St Louis, MO, and it's been added/updated in Multiple Myeloma Category
Multiple Myeloma: Relapsed Disease by Luciano Costa MD PhD from Marry and Bill Battle Professor in Multiple Myeloma, Director of Multiple MyelomaProgram, University of Alabama, Birmingham, AL, and it's been added/updated in Multiple Myeloma Category
How I Plan to use CAR-T Cells Post 1st Relapse in Multiple Myeloma by Al-Ola A Abdallah, MD from Associate Professor Director, Plasma Cell Disorder Program Division of Hematologic Malignancies & Cellular Therapeutics University of Kansas Medical Center , and it's been added/updated in Multiple MyelomaCategory
Novel Treatment Options Beyond BCMA by Muhamed Baljevic MD from Associate Professor of Medicine, Director, Plasma Cell Disorders Research and Amyloidosis Multidisciplinary Program, Vanderbilt-Ingram Cancer Center, Nashville, TN, and it's been added/updated in Multiple Myeloma Category
Multiple Myeloma : The future of Stem Cell Transplantation by Natalie Callander MD from Professor of Medicine, Director of the UW Carbone Cancer Center Myeloma Clinical Program, Divison of Hematology/BMT, UW-Madison Department of Medicine, WI, and it's been added/updated in Multiple Myeloma Category
Multiple Myeloma & The Kidneys by Nelson Leung MD from Division of Hematology, Mayo Clinic, Rochester, MN, and it's been added/updated in MultipleMyeloma Category
Multiple Myeloma: How I choose between CAR-Ts and Bispecific Antibodies by Nitya Nathwani, M.D. from Associate Professor, Division of Myeloma, Department of Hematology & Hematopoietic Cell Transplantation City of Hope, Duarte CA , and it's been added/updated in Multiple Myeloma Category
Multiple Myeloma: Front-line Therapy by Ajay Nooka MD, MPH from Professor of Medicine, Emory University, Atlanta GA , and it's been added/updated in Multiple Myeloma Category
MGUS and Smoldering Myeloma by Prashant Kapoor M.D. from Associate Professor of Medicine, Mayo Clinic, Rochester, MN, and it's been added/updated in Multiple Myeloma Category
Autologous Stem Cell Transplantation by Dr. Joshua Richter from Associate Professor of Medicine, Director of Myeloma, Blavatnik Family- Chelsea Medical Center, Mount Sinai School of Medicine, New York, NY, and it's been added/updated in Multiple Myeloma Category
Measurable Residual Disease by Adriana Rossi MD from Assistant Professor Co-Director CAR-T Program Myeloma center of Excellence Mt Sinai Hospital New York, and it's been added/updated in Multiple Myeloma Category
Isatuximab:For Front-line Transplant Ineligible Patients by Adriana Rossi MD from Assistant Professor Director CAR-T and Stem Cell Transplant Clinical Program Mt Sinai Hospital New York , and it's been added/updated in Multiple Myeloma Category
How I Approach Front Line Treatment for Patients with Myeloma by Sagun D Goyal, MD Msc from Associate Professor of Medicine, Director of Bone Marrow Transplant & Cellular Therapy, Saint Louis University School of Medicine, SSM St Louis University Hospital, and it's been added/updated in MultipleMyeloma Category
Will CAR-Ts and bispecifics eliminate HSCT for Multiple Myeloma? by Samer Al Hadidi, M.D., M.S. (CRDSA), FACP from Assistant Professor MyelomaCenter, Winthrop P. Rockefeller Cancer Institute University of Arkansas for Medical Sciences Little Rock, AR , and it's been added/updated in Multiple MyelomaCategory
How I Manage Multiple Myeloma In The Elderly by Sascha Alexander Tuchman, MD, MHS from Professor of Medicine Director, Multiple Myeloma and Amyloidosis Program UNC School of Medicine , and it's been added/updated in Multiple Myeloma Category
How I Treat Triple Class Refractory Multiple Myeloma by Susan Bal MD from Assistant Professor Medicine- Hematology & Oncology University of Alabama at Birmingham , and it's been added/updated in Multiple Myeloma Category
How The Pegasus and Iskia Trials Influence My Decision on Induction Therapy For Transplant Eligible Patients with Multiple Myeloma by Tom Martin MD from Professor of Medicine Associate Chief, Hematology and Oncology Helen Diller Family Comprehensive Cancer Center UCSF , and it's been added/updated in Multiple Myeloma Category
Updates from American Society of Hematology 2022 Meeting: CAR-T Cells by Jeffrey Zonder,M.D. from Barbara Ann Karmanos Cancer Institute Wayne Sate University School of Medicine Detroit, MI. , and it's been added/updated in Multiple Myeloma Category
ASCO 2023 Highlights : Myeloma by Luciana Costa MD PhD from Marry and Bill Battle Professor in Multiple Myeloma, Director of Multiple Myeloma Program, University of Alabama, Birmingham, AL, and it's been added/updated in Multiple Myeloma Category
Updates from American Society of Hematology 2022 Meeting: Bispecifics by Peter Voorhees, MD from Chief of the Plasma Cell Disorders Division, Levine Cancer Institute, Charlotte, NC, and it's been added/updated in Multiple Myeloma Category
Here are the latest posts last week:
Blogs :
Dr. Banerjee discusses the impact of dose modification studies in multiple myeloma.
Evaluating Combination Strategies in R/R Multiple Myeloma: TRIMM-2, TRIMM-3, and MajesTEC-3
Overview of the MonumenTAL-2 and MonumenTAL-3 Studies
Overview of Additional Clinical Trials for GPRC5D Therapies
Dr. Lonial discusses CoMMpass Study’s impact on personalized multiple myeloma treatment.
New Study Reveals Disparities in Time to Oral Antimyeloma Treatment
Administration and Dosing Guidelines
Dr. Banerjee discusses benefits of bispecific antibody dose reduction in myeloma.
Also at MCH the News and Tweets never stop flowing!
Join Us at www.mycancerhaven.org
The Team @ MCH
Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok
Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.
We wanted to update you on our recent activities.
We've added below videos to our Videos repository.
The video is titled
Multiple Myeloma: Introduction by Shaji Kumar MD from Professor of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, and it's been added/updated in Multiple Myeloma Category
Multiple Myeloma: Introduction by Shaji Kumar MD from Professor of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, and it's been added/updated in Multiple Myeloma Category
Ready for the return of Belantamab Mafodotin? by Ajai Chari, MD from Professor of Medicine Director of Myeloma Program University of California San Francisco , and it's been added/updated in Multiple Myeloma Category
High Risk Myeloma by Melissa Alsina MD from Professor of Medicine, Head Myeloma Section, Blood and Marrow Transplant and Cellular Immunotherapy Program, Moffitt Cancer Center, Tampa FL, and it's been added/updated in Multiple Myeloma Category
How I Manage Patients Long-Term Post CAR-T and Bispecifics Treatment by Binod Dhakal MD from Associate Professor of Medicine Division of Hematology Medical College of Wisconsin , and it's been added/updated in Multiple Myeloma Category
Multiple Myeloma: How I Treat First Relapse(1) by Brea Lipe from Professor of Medicine, Clinical Director Multiple Myeloma Program, James P. Wilmot Cancer Center, University of Rochester Medical Center, NY, and it's been added/updated in Multiple Myeloma Category
Multiple Myeloma: How I Treat First Relapse(2) by Brea Lipe from Professor of Medicine, Clinical Director Multiple Myeloma Program, James P. Wilmot Cancer Center, University of Rochester Medical Center, NY, and it's been added/updated in Multiple Myeloma Category
How to Interpret Your Test Results by Craig Emmitt Cole, MD from Division of Hematology and Oncology, Karmanos Cancer Institute at McLaren Greater Lansing, Michigan State University College of Human Medicine, and it's been added/updated in Multiple Myeloma Category
How I Use Selinexor in My Practice by Cristina Gasparetto, MD from Professor of Medicine Director of Duke Multiple Myeloma Program Duke University Medical center Durham, NC , and it's been added/updated in Multiple Myeloma Category
Peripheral Neuropathy by Beth Faiman PhD, MSN, APN-BC, BMTCN, AOCN, FAAN, FAPO from Department of Hematologic Oncology, Cleveland Clinic, Cleveland, Ohio, and it's been added/updated in Multiple Myeloma Category
How I Treat Amyloidosis by Jeffrey A. Zonder, M.D. from Professor of Medicine, Department of Oncology Barbara Ann Karmanos Cancer Institute Wayne State University School of Medicine Detroit, MI , and it's been added/updated in Multiple Myeloma Category
How I Manage The Side-Effects of Talquetamab by Dr. Joshua Richter MD from Associate Professor of Medicine Tisch Cancer Institute Director of MyelomaBlavatnik Family-Chelsea Medical Center Mount Sinai School of Medicine New York, NY , and it's been added/updated in Multiple Myeloma Category
Amyloidosis by Keith Stockerl-Goldstein MD from Co-Director of Amyloid Center of Excellence, Professor of Medicine, Division of Medical Oncology, Washington University, St Louis, MO, and it's been added/updated in Multiple Myeloma Category
Multiple Myeloma: Relapsed Disease by Luciano Costa MD PhD from Marry and Bill Battle Professor in Multiple Myeloma, Director of Multiple MyelomaProgram, University of Alabama, Birmingham, AL, and it's been added/updated in Multiple Myeloma Category
How I Plan to use CAR-T Cells Post 1st Relapse in Multiple Myeloma by Al-Ola A Abdallah, MD from Associate Professor Director, Plasma Cell Disorder Program Division of Hematologic Malignancies & Cellular Therapeutics University of Kansas Medical Center , and it's been added/updated in Multiple MyelomaCategory
Novel Treatment Options Beyond BCMA by Muhamed Baljevic MD from Associate Professor of Medicine, Director, Plasma Cell Disorders Research and Amyloidosis Multidisciplinary Program, Vanderbilt-Ingram Cancer Center, Nashville, TN, and it's been added/updated in Multiple Myeloma Category
Multiple Myeloma : The future of Stem Cell Transplantation by Natalie Callander MD from Professor of Medicine, Director of the UW Carbone Cancer Center Myeloma Clinical Program, Divison of Hematology/BMT, UW-Madison Department of Medicine, WI, and it's been added/updated in Multiple Myeloma Category
Multiple Myeloma & The Kidneys by Nelson Leung MD from Division of Hematology, Mayo Clinic, Rochester, MN, and it's been added/updated in MultipleMyeloma Category
Multiple Myeloma: How I choose between CAR-Ts and Bispecific Antibodies by Nitya Nathwani, M.D. from Associate Professor, Division of Myeloma, Department of Hematology & Hematopoietic Cell Transplantation City of Hope, Duarte CA , and it's been added/updated in Multiple Myeloma Category
Multiple Myeloma: Front-line Therapy by Ajay Nooka MD, MPH from Professor of Medicine, Emory University, Atlanta GA , and it's been added/updated in Multiple Myeloma Category
MGUS and Smoldering Myeloma by Prashant Kapoor M.D. from Associate Professor of Medicine, Mayo Clinic, Rochester, MN, and it's been added/updated in Multiple Myeloma Category
Autologous Stem Cell Transplantation by Dr. Joshua Richter from Associate Professor of Medicine, Director of Myeloma, Blavatnik Family- Chelsea Medical Center, Mount Sinai School of Medicine, New York, NY, and it's been added/updated in Multiple Myeloma Category
Measurable Residual Disease by Adriana Rossi MD from Assistant Professor Co-Director CAR-T Program Myeloma center of Excellence Mt Sinai Hospital New York, and it's been added/updated in Multiple Myeloma Category
Isatuximab:For Front-line Transplant Ineligible Patients by Adriana Rossi MD from Assistant Professor Director CAR-T and Stem Cell Transplant Clinical Program Mt Sinai Hospital New York , and it's been added/updated in Multiple Myeloma Category
How I Approach Front Line Treatment for Patients with Myeloma by Sagun D Goyal, MD Msc from Associate Professor of Medicine, Director of Bone Marrow Transplant & Cellular Therapy, Saint Louis University School of Medicine, SSM St Louis University Hospital, and it's been added/updated in MultipleMyeloma Category
Will CAR-Ts and bispecifics eliminate HSCT for Multiple Myeloma? by Samer Al Hadidi, M.D., M.S. (CRDSA), FACP from Assistant Professor MyelomaCenter, Winthrop P. Rockefeller Cancer Institute University of Arkansas for Medical Sciences Little Rock, AR , and it's been added/updated in Multiple MyelomaCategory
How I Manage Multiple Myeloma In The Elderly by Sascha Alexander Tuchman, MD, MHS from Professor of Medicine Director, Multiple Myeloma and Amyloidosis Program UNC School of Medicine , and it's been added/updated in Multiple Myeloma Category
How I Treat Triple Class Refractory Multiple Myeloma by Susan Bal MD from Assistant Professor Medicine- Hematology & Oncology University of Alabama at Birmingham , and it's been added/updated in Multiple Myeloma Category
How The Pegasus and Iskia Trials Influence My Decision on Induction Therapy For Transplant Eligible Patients with Multiple Myeloma by Tom Martin MD from Professor of Medicine Associate Chief, Hematology and Oncology Helen Diller Family Comprehensive Cancer Center UCSF , and it's been added/updated in Multiple Myeloma Category
Updates from American Society of Hematology 2022 Meeting: CAR-T Cells by Jeffrey Zonder,M.D. from Barbara Ann Karmanos Cancer Institute Wayne Sate University School of Medicine Detroit, MI. , and it's been added/updated in Multiple Myeloma Category
ASCO 2023 Highlights : Myeloma by Luciana Costa MD PhD from Marry and Bill Battle Professor in Multiple Myeloma, Director of Multiple Myeloma Program, University of Alabama, Birmingham, AL, and it's been added/updated in Multiple Myeloma Category
Updates from American Society of Hematology 2022 Meeting: Bispecifics by Peter Voorhees, MD from Chief of the Plasma Cell Disorders Division, Levine Cancer Institute, Charlotte, NC, and it's been added/updated in Multiple Myeloma Category
Here are the latest posts last week:
Blogs :
Dr. Banerjee discusses the impact of dose modification studies in multiple myeloma.
Evaluating Combination Strategies in R/R Multiple Myeloma: TRIMM-2, TRIMM-3, and MajesTEC-3
Overview of the MonumenTAL-2 and MonumenTAL-3 Studies
Overview of Additional Clinical Trials for GPRC5D Therapies
Dr. Lonial discusses CoMMpass Study’s impact on personalized multiple myeloma treatment.
New Study Reveals Disparities in Time to Oral Antimyeloma Treatment
Administration and Dosing Guidelines
Dr. Banerjee discusses benefits of bispecific antibody dose reduction in myeloma.
Also at MCH the News and Tweets never stop flowing!
Join Us at www.mycancerhaven.org
The Team @ MCH
Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok
Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.
